Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Marcaine for Postoperative Pain in Spinal Fusion
NCT03476811Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Feb 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine hydrochloride injection 0.25% in postoperative pain, sponsored by University of Arizona. Started Feb 2018; status: completed.
02
Drugs
bupivacaine hydrochloride injection 0.25%
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03476811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476811.